
Elixion Biotech is a biotechnology company based in Zurich, focused on developing novel therapeutics by integrating quantum physics, causal biology, multi-omics, and native AI. Their R&D approach aims for greater precision and speed in drug discovery, with a patient-centric focus. The company is built by experts from pharma, business, finance, AI, and biosciences, emphasizing data-driven impact. Their business model likely involves R&D services and licensing of developed therapeutics.

Elixion Biotech is a biotechnology company based in Zurich, focused on developing novel therapeutics by integrating quantum physics, causal biology, multi-omics, and native AI. Their R&D approach aims for greater precision and speed in drug discovery, with a patient-centric focus. The company is built by experts from pharma, business, finance, AI, and biosciences, emphasizing data-driven impact. Their business model likely involves R&D services and licensing of developed therapeutics.